Answers are grounded in this paper and cite their sources.
Randomized clinical trials show fluralaner effectively controls mange in dogs, suggesting simplified treatment options.
Abstract Background Parasitic dermatopathies account for approximately 30% of cases in veterinary clinics, primarily caused by ticks, fleas, and mites. Parasitic mites cause mange, a term used to describe a type of skin disease. One of the most relevant parasitic Acari is Sarcoptes scabiei, which causes sarcoptic mange, mainly called scabies in humans. This condition is highly contagious, affects various mammals and humans, leading to intense itching and skin lesions. Another significant mite is Otodectes cynotis, the "ear mite", which is the primary cause of external otitis in mammals, causing severe ear itching. The treatment and control of these forms of mange rely on the use of antiparasitics, such as fluralaner, which acts by paralyzing and killing the parasites. Methods Two clinical studies were conducted to evaluate the acaricide efficacy against these mites. Both studies utilized 14 animals each, divided into a Control Group (n = 7), treated with a reference product based on sarolaner, and a Treated Group (n = 7) treated with WellPet™ (a palatable tablet based on fluralaner, 10 to 22.5 mg/kg – Ourofino Saúde Animal Ltda.). Acaricide efficacy was assessed through mite counts and evaluation of lesions resulting from the diseases. Results There was no statistical difference in the comparison between the Treated and Control groups in either trial. WellPet™ demonstrated 100% efficacy against sarcoptic mange after a single administration, unlike the reference product, which required two monthly administrations. For otodectic mange, both products reached adequate efficacy after a single use. Conclusions The WellPet™ product, a novel ectoparasiticide based on fluralaner, proved to be highly effective in the treatment of both sarcoptic and otodectic mange, with results similar to those of sarolaner. The main advantage of WellPet™ is the ability to achieve complete cure of sarcoptic mange with a single dose, thereby simplifying disease management. For otodectic mange, both products were highly effective. In summary, WellPet™ is an effective and practical treatment option for these types of mange.
No takes yet. Share an insight, caveat, or question.
Cruz et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: